The high economic burden of preeclampsia

This is the first study using primary data to uncover the economic burden of preeclampsia. Read to find out just how high the burden is on our healthcare system.

Preeclampsia is a growing issue, but little is known about the cost to our healthcare system.

In a collaboration between Progenity and Geisinger, a large regional healthcare system, >2,100 mother/infant pairs were matched and evenly distributed among three cohorts of normal, hypertensive, and preeclamptic pregnancies. Primary data from their Geisinger electronic medical and billing records was used to estimate differences in their healthcare costs.

What did we find?

  • Preeclamptic pregnancies were on average $28,603 more costly than normal pregnancies and $17,608 more costly than hypertensive pregnancies (2015 U.S. dollars).1
  • The mean infant cost in the preeclamptic pregnancies was $28,898, almost 8 times greater than for the normal cohort of $3,669 and more than double the hypertension cohort of $12,648 (2015 U.S. dollars). 1
  • The healthcare costs of preeclampsia are significant and primarily driven by high infant costs linked to premature delivery (3 weeks earlier compared to normal and more than 2 weeks earlier for hypertension) and other adverse events. Additionally, women with preeclampsia had higher rates of C-section deliveries and maternal adverse events.1


This research was presented at the 2019 Society for Maternal-Fetal Medicine (SMFM) Annual Pregnancy Meeting.

Download the poster

Have questions?

Dive deeper on how this research uniquely impacts your practice by contacting us.

Email us


  1. Hao et al. Economic Burden of Preeclampsia: Maternal and Infant Healthcare Costs. Poster presented at Society for Maternal-Fetal Medicine (SMFM) Annual Pregnancy Meeting 2019. Las Vegas, NV.